Back
Sangamo Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
SGMO
Sponsored
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.
Sell
29
SGMO
Sangamo Therapeutics
Last Price:
0.53
Seasonality Move:
-2.28%
7 Day Trial
ALL ACCESS PASS
$
7
9,530x the last time this happened
Here's what our expert says you should buy before April 14.Sangamo Therapeutics Price Quote
$0.53
+0.01 (+1.53%)
(Updated: May 3, 2024 at 12:55 PM ET)
Sangamo Therapeutics Key Stats
Sell
29
Sangamo Therapeutics (SGMO)
is a Sell
Day range:
$0.52 - $0.57
52-week range:
$0.29 - $1.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.52
P/B ratio:
1.13%
Volume:
746.6K
Avg. volume:
1.8M
1-year change:
-61.9%
Market cap:
$93.4M
Revenue:
$176.2M
EPS:
$-1.47
How Much Does Sangamo Therapeutics Make?
-
How Much Are Sangamo Therapeutics's Sales Annually?
SGMO Revenues are $176.2M -
How Much Profit Does Sangamo Therapeutics's Make A Year?
SGMO net income is -$257.8M
Is Sangamo Therapeutics Growing As A Company?
-
What Is Sangamo Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.93% -
What Is Sangamo Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sangamo Therapeutics Stock Price Performance
-
Did Sangamo Therapeutics Stock Go Up Last Month?
Sangamo Therapeutics share price went down by -10.22% last month -
Did SGMO's Share Price Rise Over The Last Year?
SGMO share price fell by -61.9% over the past 1 year
What Is Sangamo Therapeutics 52-Week High & Low?
-
What Is Sangamo Therapeutics’s 52-Week High Share Price?
Sangamo Therapeutics has traded as high as $1.67 over the past 52 weeks -
What Is Sangamo Therapeutics’s 52-Week Low Share Price?
Sangamo Therapeutics has traded as low as $0.29 over the past 52 weeks
Sangamo Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sangamo Therapeutics?
-
How Much Debt Does Sangamo Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sangamo Therapeutics Have?
Cash and short term investments quarterly total is $81M -
What Is Sangamo Therapeutics’s Book Value Per Share?
Book value per share is 0.47
Is Sangamo Therapeutics Cash Flow Positive?
-
What Is SGMO Cash Flow From Operations?
Cash flow from operations (TTM) is -$224.8M -
What Is Sangamo Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $14.6M -
What Is Sangamo Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $153.5M
Sangamo Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SGMO return on invested capital is -119.14% -
What Is Sangamo Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -75.25% -
What Is SGMO Return On Equity?
ROE is a measure of profitability and is -119.14%
Sangamo Therapeutics Earnings Date & Stock Price
-
What Is Sangamo Therapeutics's Stock Price Today?
A single share of SGMO can be purchased today for 0.52 -
What Is Sangamo Therapeutics’s Stock Symbol?
Sangamo Therapeutics trades on the nasdaq under the ticker symbol: SGMO -
When Is Sangamo Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sangamo Therapeutics is scheduled on May 3, 2024 -
When Is SGMO's next ex-dividend date?
Sangamo Therapeutics's next ex-dividend date is May 3, 2024 -
How To Buy Sangamo Therapeutics Stock?
You can buy Sangamo Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sangamo Therapeutics Competitors
-
Who Are Sangamo Therapeutics's Competitors?
Below is a list of companies who compete with Sangamo Therapeutics or are related in some way:
Sangamo Therapeutics Dividend Yield
Data Unavailable
Sangamo Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -8.97% |
Revenue: | -92.5% | -74.81% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 4 |
Sell Recommendations: | 0 |
Price Target: | 3.50 |
Upside from Last Price: | 570.5% |